IL6 and cardiac hypertrophy: Its effects on cardiac contractility reduction [89] and LV (left ventricular) remodeling- fibrosis, hypertrophy and dilatation [90, 91], support the association between IL-6 and development of end-organ damage in hypertensive patients.